Skip to main content
You have permission to edit this article.
Edit

FDA crackdown targets unpublished research results

Front One Top

(The Center Square) – The U.S. Food and Drug Administration issued more than 2,200 notices urging companies and researchers to comply with federal publication rules. 

A recent FDA crackdown highlights transparency issues in clinical research, as thousands of companies and researchers have failed to disclose required trial results. Some of the agency’s reminders went to taxpayer-funded projects.

Keep reading

Originally published on thecentersquare.com, part of the BLOX Digital Content Exchange.

Our Standards

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

Test polling

You voted:

Test Most Popular Grid

Global Side Primary

300 x 250 300 x 600